Consistent with the ANG II plasma AVP results, CNO pretreatment significantly attenuated this increase in the Gi DREADD + CNO + 3% HTN group (p = 0.008, Tukey’s post hoc analysis). The gene discussed is AGT; the disease is hypertensive disorder.